TGFBR2 and neuroblastoma: For example, miR-186 limits NB expression of MYCN, AURKA, TGF-βR1 and TGF-βR2, to reduce TGF-β-mediated immune escape, restrict tumorigenesis, and enhance NB cytotoxicity (95).